The aim of this article is to analyze the tissue expression of EGFR, Beta catenin, cyclin D1, CDK4, and ErbB2 in pancreatic cancer in order to find their association with the mortality and survival of patients with this tumor. The gene discussed is EGFR; the disease is pancreatic neoplasm.